AccessHope, a company transforming the delivery of leading-edge cancer expertise, announced that it had raised $33 million in a Series B round of funding from the City of Hope, one of the US’ largest cancer research and treatment organizations.
AccessHope’s next growth phase as a stand-alone company will include product and technology development, oncology network expansion, and entry into new markets like health plans, Medicare, and government organizations.
AccessHope appointed seasoned healthcare, payer, and investment veteran Bradley Kreick as its new CEO to drive its transformation into a commercial business. Kreick – who has served on the AccessHope board since last year – brings 30 years of experience leading companies through periods of significant growth.
AccessHope experienced double-digit growth every year since its founding. Its collaboration with foundational partners drives this success, including many of the country’s most elite National Cancer Institute (NCI)-Designated Comprehensive Cancer Centers. With this first-of-its-kind approach, AccessHope has joined forces with these NCI Centers to mobilize the latest cancer insights to support local oncologists in developing precise treatment plans for their patients.
AccessHope’s foundational partners currently include the founder City of Hope, Dana-Farber Cancer Institute, Emory Healthcare and Winship Cancer Institute of Emory University, Fred Hutch Cancer Center, Johns Hopkins Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and Northwestern Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. With these collaborations, AccessHope members now have access to expertise from over 350 of the world’s top oncologists, covering all cancer types and stages.
With Kreick’s CEO addition, AccessHope is building a solid team positioned to take the company to the next level of growth as a commercial business. And Mark Stadler, a veteran employee benefits and healthcare executive who led AccessHope through its momentous growth as CEO since 2020, will assume the role of Chief Growth Officer. In this new role, Stadler will focus on expanding cancer care benefits through health plans, Medicare and government markets.
Kreick most recently served as CEO of SolutionHealth, which an integrated regional health system formed in 2018 by the combination of the Elliot Health System and Southern New Hampshire Health System. He was also a co-investor with The Blackstone Group as part of its 2008 acquisition of then publicly traded Apria Healthcare, which is the nation’s largest home care provider. At Apria, he was EVP, Payor Arrangements and Pricing for four years. Earlier in his career, Kreick served as EVP, Business Development for Oxford Health Plans (acquired by UnitedHealth Group in 2004) following Texas Pacific Group’s private equity investment.
KEY QUOTE:
“AccessHope was founded with the mission of bringing cutting-edge cancer care knowledge to the places and people who need it most. Today, we are proud to serve nearly seven million members through more than 400 employers, including over 60 Fortune 500 companies and two of the nation’s largest health plans. As demand for personalized cancer care benefits offered by AccessHope continues to grow, it is an ideal time for City of Hope to provide strategic funding and the autonomy for it to operate as a stand-alone company. This move will enable AccessHope to accelerate innovation and expand into new markets and regions, while continuing to extend access to the best cancer treatment expertise regardless of who you are and where you live.”
– Harlan Levine, M.D., chair of the AccessHope board and president, Health Innovation and Policy at City of Hope
